April 19, PharmAust Receives $708k R&D Tax Rebate
220419_RDtaxrebate
220401_Top_Holders_Movements_Report
220315_Top_Holders
220221_Ergomed Investigate COVID Trial
220218_Appendix4D and Half Year Update
Epichem JTSI e-waste Presentation Final
220204_Resignation of Epichem CEO
220202 Monepantel Tablets for Human Clinical Trials_
220201_Top_Holders_Report